Simulating patient pathways enables providers, payers as well as pharmaceutical and medical device companies to understand how patients with particular conditions currently use services and to experiment with changes to existing flows as a result of new interventions, allowing users to understand the impact on demand, activity, cost, capacity and waiting times.
Economic evaluations take place when a new drug or device is being taken to market and is also used by healthcare payers and providers when considering whether to adopt any innovation, including new drugs or devices.
Clinicians and administrators need to understand not just whether the new intervention is cost effective when applied to theoretical cohorts of patients, but also what it would mean when implemented in their own organization or health economy.
System Resilience
Simulation used to demonstrate organizational resilience across Oxfordshire against the ten compliance priorities identified by the UK NHS South Central. It focuses on the management structures within and between organizations and evidence of the rigorous processes in place to manage increased demand and ensure maintenance of high quality care in times of system challenge.
Test System Changes
A health system wanted to test resilience plans to ensure that patients would be cared for in the case of additional demand such as occurs during the winter time. They built a simulation to model emergency care from ambulance calls through the emergency department to the management of beds and used the model to test their emergency plans.
We have developed this free resource to enable health economists and decision-makers new to SIMUL8 to learn how to use the software for this purpose. It takes you through the key features via a case study and explains how to use them to get you up and running quickly.
To find out more contact us on 800 547 6024 and we’ll be happy to discuss how including simulation into Health Economics could benefit you and your organization.
From medical device manufacturing to device & resource adoption, simulation is being used for a whole range of functions in the healthcare device industry.
Pharmaceutical companies are investing in simulation to support a whole range of business functions, from manufacturing, clinical trials and drug adoption.
SIMUL8 Market Access is a new solution that enables you to share dynamic patient pathway models with clients. SIMUL8 Market Access transforms communication and adds value to your partnerships, helping stakeholders make informed decisions, add value to their organizations and understand the impact of any changes.
Posted in the Journal of Applied Sciences. Simulating the care of people with Type 2 Diabetes through the Indian System of Medicine called Ayurveda. The model incorporates Prameha risk groupings and follows individual patients through the system.
This report quantifies the activities, costs and outcomes, associated with the current treatment of bowel cancer in England and, using SIMUL8 simulation software, predicts the costs and outcomes of options for re-configuration of bowel cancer services.
A systematic review and an economic evaluation of Diagnostic management strategies for adults and children with minor head injuries in the UK Health System.
If you're considering simulation for your next project, our team are happy to help.
Explore SIMUL8 Professional's features with a free 14 day online trial.
